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Initial Experience of a Digital Training Resource for
Modified Rankin Scale Assessment in Clinical Trials
Terence J. Quinn, MRCP; Kennedy R. Lees, MD; Hans-Goran Hardemark, PhD;
Jesse Dawson, MRCP; Matthew R. Walters, MD
Background and Purpose—The modified Rankin Scale (mRS) is the preferred measure of disability in cerebrovascular
clinical trials, but its value is restricted by interobserver variability. Poor reliability reduces the statistical power of
clinical trials and leads to underestimation of effect size. Strategies to improve mRS grading are required. Video training
has previously improved application of the National Institutes of Health Stroke Scale in clinical research. We developed
an mRS training resource in an attempt to minimize interobserver variability.
Methods—We produced a complete training resource comprising an instructional DVD with accompanying written
materials and assessment recordings of patient interviews. Formal assessment of training involved grading of real-life
cases. Results of initial training and recertification were collected centrally and scored.
Results—Data from 1564 assessments are presented. The majority of assessors were participating in 2 large prospective
clinical stroke trials. Assessors represented a mixed group of disciplines and nationalities. After training, most trainees
(90%) achieved certification in mRS assessment. The majority (85%) of investigators who did not reach an acceptable
score on initial testing achieved certification after further exposure to the package.
Conclusions—Mass training in mRS assessment for clinical trials is possible. We outline the development of a video-based
training package, including technical issues, patient selection procedures, and methods of scoring and assessment.
Certification results suggest that use of the resource can improve mRS grading. Acceptability of the training has been
demonstrated by its successful use in 2 international acute stroke trials, SAINT 1 and CHANT. (Stroke. 2007;38:2257-2261.)
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Assessment of recovery from stroke requires a valid andreliable outcome measure. The modified Rankin Scale
(mRS) is now the preferred disability end point for clinical
trials1 and has been used in a number of interventional
studies.2,3 It is an ordinal hierarchical scale incorporating 6
categories that describe the range of disability encountered
after stroke.4 Although widely used, the mRS has been
criticized for its relative lack of structure5: Rankin grades
encompass a broad range of potential outcomes, and bound-
aries between grades are poorly defined relative to other
outcome assessment instruments. This lack of structure is
reflected by the high interobserver variability seen when the
mRS is applied. Single-center studies typically give weighted
 statistics between 0.7 and 0.8,6 whereas a 3-site comparison
designed to simulate a multicenter trial reported an un-
weighted  statistic of only 0.25 with the standard mRS
assessment.7
Various strategies have been proposed to improve reliabil-
ity, including video recording8 and use of a structured
interview.7,9 Improving reliability of the mRS is of more than
clinimetric interest; interobserver variability will increase the
risk of end-point misclassification, which can introduce bias
and affect type II error rates.10 Estimated effect size will be
reduced. It has been argued that the statistical underpowering
has contributed to the lack of significant treatment effects
seen in recent acute stroke trials.11
Use of a training resource to improve consistency in the
application of the mRS makes intuitive sense.12 In the original
work describing interobserver variation in mRS scoring, the
authors commented that improvements could be achieved if
observers were afforded the chance to practice use of the
scale, but that “. . . such training is hardly realistic in the
context of a multicenter trial.”4 Recent improvements in
audiovisual technology mean mass training across a number
of centers is now feasible.
A variety of potential formats are available for training. A
stand-alone package would allow better standardization and
dissemination than a lecture-based series, whereas a program
incorporating “live” assessment of real patients is preferable
to purely text-based instruction. The former approach is not
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without precedent. A well-validated video-based training
program and certification procedure exist for the National
Institutes of Health Stroke Scale (NIHSS), and it is now a
requirement that clinical trial investigators complete this
training and undergo certification.13 The strengths of the
NIHSS program, in particular its mix of didactic teaching,
video explanation, and assessment procedure, could be easily
applied to the mRS.
We developed a training DVD and accompanying explan-
atory booklet, which include recordings of real Rankin
assessments, certification cases, and further recertification
cases. This has been used successfully in 2 large-scale clinical
stroke trials.14,15 Although brief reference to certification
scoring has been made in a previous review,16 to date there
has been no detailed description of the training package, its
development, and the initial experience of its use. We present
this here along with the results of the certification program.
Materials and Methods
Development of the Training Package:
Audiovisual Issues
A criticism of the early NIHSS video training was poor image
quality, an important consideration, as subtle clinical signs may have
a substantial effect on final scoring.16 In an interview-based assess-
ment such as the mRS, high-quality sound recording is of equal
importance. We enlisted expert technical help (Media Services
Department, University of Glasgow). A recording studio was used
and, where patient disability made travel to the studio inappropriate,
the Media Services mobile crew filmed in the hospital.
We chose a DVD-based format. This reflects the gradual replace-
ment of conventional VHS recordings with DVD and the improved
clarity of sound and vision afforded by it. Digital recording ensures
optimal quality, even after mass reproduction. Finally, this allows for
ease of transfer to a Web-based server. Internet-based NIHSS
training has facilitated cost-effective global dissemination of the
training package.
Patient Selection
The stroke liaison team based in the Western Infirmary, Glasgow,
selected suitable patients from recent admissions to the acute stroke
unit or local inpatient rehabilitation facility. The stroke unit accepts
all patients presenting within 72 hours of onset of suspected stroke,
irrespective of age or severity of the neurologic deficit; thus, a cohort
of patients with varying degrees of disability and background
comorbidity was available. Our intention was to include at least 1
patient from each potential mRS category. Thirteen patients were
selected, of whom 4 were designated as training cases, 5 were used
for initial assessment, and 4 were used for recertification. To reflect
clinical practice, in 1 case disability was sufficiently severe that
answers were provided by a caregiver. Although the final selection
of patients was a sample of convenience, they were though to be
representative of a “real-life” cross section of poststroke outcomes
and to be suitable for inclusion in the training package. We obtained
a consent for videotaping and use for training and research purposes
from all patients, in line with national and local protocols.
For the training component of the package, 2 patients with easily
categorized disability were chosen as initial “introductory” cases.
The remaining 2 training cases were chosen to highlight perceived
problem areas in the application of the scale. Each of the training
cases was followed by an explanatory discussion of the correct mRS
score and the rationale for this grading. An accompanying booklet
gave background information on the general principles of mRS
scoring, including detailed definitions of the categories and discus-
sion of what is considered to be best practice in the application of the
scale. In formulating this advice, we made reference to the original
description of the mRS and to recent work by means of a structured
interview.4 To minimize potential language problems, we provided a
transcript of the text with translation into local language. Fully
translated training packages, with native speakers overdubbing the
interview, have been made available for Spanish, Portuguese, and
Italian researchers; a subtitled Chinese version has also been pro-
duced. Assessment for certification was performed in a variety of
settings, including individual viewing of the cases, group viewing
within a center, and supervised group viewing sessions at formal
training meetings.
Recording and Scoring of the Assessments
Recordings of the interviews were analyzed and scored indepen-
dently by 2 observers who were both experienced in mRS grading
(K.R.L. and H.G.H.). No attempt was made to “script” the mRS
assessments, and there was little postinterview editing. During a pilot
run of the study, we immediately identified that some of the answers
given by patients were ambiguous, and in at least 2 of the cases,
debate arose as to the most appropriate category. However, a
decision was made to keep the complete interviews as recorded; it
was thought that scenarios artificially scripted to fit an mRS grade
neatly would not have adequately prepared assessors for the diffi-
culties inherent in grading real patients.
Scoring for the assessment component of the package took
account of those patients who did not unequivocally fit a single
grade. A final decision on correct grading was made by K.R.L. and
H.G.H., supplemented by analysis of the results from an international
pilot study involving 100 participants. We defined a correct grade as
one assigned by both trainers and by 50% of trainees. A grade of
an “acceptable” response was defined arbitrarily as one that was
deemed by the trainers to be incorrect but that followed the basic
scoring guidelines and had been assigned by a substantial minority
(10% to 49%) of assessors in the pilot. Any grade offered by 10%
of assessors or that clearly did not follow the accepted scoring was
defined as “unacceptable.” According to these scoring rules, any
candidate who graded all cases correctly, including “acceptable”
answers, was awarded certification (Table 1). This scoring system
was developed so that certification was awarded only to those
assessors who demonstrated a good knowledge of the mRS applica-
tion but recognized that some merit should be given for “acceptable”
but incorrect answers. To minimize variability, we instructed asses-
sors to choose the more severe mRS grade when hesitating between
2 scores.
We awarded certificates of completion, along with separate
confidential feedback on the actual score achieved, to all who
achieved the target. Scores for individual patients were not released.
We encouraged assessors who did not achieve certification on their
first attempt to review the training material and resubmit an amended
set of grades for the full set of certification cases. We gave no
specific feedback on their errors.
Results
Between March 2003 and May 2006, investigators from
25 countries submitted the end-of-training assessment.
Data are available on 1800 assessments. The assessors
were a mixed group of principal investigators and coin-
vestigators, study nurses, and research assistants (Table 2).
The majority of respondents were part of the investigating
team from countries involved in the Stroke–Acute Ische-
mic–NXY-059 Treatment (SAINT-I)14 trial only or in both
TABLE 1. Scoring System for Certification Process
Grading Certification
All 5 cases correct Pass (qualified 5)
4 correct cases and 1 acceptable Pass (qualified 4)
3 correct cases and 2 acceptable Pass (qualified 3)
Any other combination Not qualified
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the SAINT-II and the Cerebral Hemorrhage and NXY-059
Treatment (CHANT) study.15
The correct mRS scores for the certification cases, along
with the proportion of scores assigned by observers, are
shown in Table 3. To allow continued use of the training
resource, the “correct” scores for assessment and recertifica-
tion were not made public and are shown in a sequence
different from the cases on the DVD.
There was a spread of opinion on all of the cases, with
submitted answers spanning 3 to 5 mRS grades for each
answer. For 3 of the cases, the majority of respondents opted
for the correct grading; in 2 of the cases, opinion was split,
with a substantial proportion of assessors (39.2% and 40.4%)
choosing a lower mRS grade than the correct answer. We
accounted for this variation in opinion in the final scoring,
and the lower grade was defined as an “acceptable” answer.
Twenty-three assessors gave 2 scores, despite explicit instruc-
tions to choose the best single score. If the scores given were
the correct and an acceptable score, then a “pass” was
allowed; otherwise, the grading was considered invalid.
Percentages of respondents achieving acceptable scores for
the certification assessment are given in Table 2. The major-
ity of assessors (1464, 81.3%), achieved a “pass” on the
certification exercise. However, only 38% of these individu-
als graded all of the 5 cases correctly. The remainder of the
group comprised those assessors who wrongly assessed 1 or
both of the previously described equivocal cases but whose
assessment was still defined as acceptable. Of the 336 who
did not achieve certification on their first attempt, 85% scored
a “pass” on a second attempt.
Demographic data on assessors submitting for certification
were collated. Results of the certification assessment are
presented by training (Table 2) and by country of origin
(Figure). We intended the recertification process to be under-
taken 1 year after the initial training, as such full data on
recertification are presently limited to 370 results. Of these,
only 6.5% assessors failed to achieve a satisfactory score
(Table 3).
Discussion
Consistency in grading of poststroke disability is crucial both
in daily clinical work and in the context of a clinical trial. For
trial purposes, consistency is more important than accuracy.
The potential for significant variation in application of the
mRS is now apparent.6 We developed a digital training
resource for mRS grading in an attempt to improve this
situation. Our results show that mass training of observers in
use of the mRS is achievable in the context of a clinical trial
via the use of a novel DVD training package.
Several issues arose during development of the DVD that
deserve comment. We used no specific criteria to select
patients for the training or certification components of the
package, although patients used for assessment were judged
to be suitably taxing to allow a valid assessment of ability. A
clustering of grades around the midrange was noted in the
cases selected to be used for the certification process. It has
been shown that clinicians are comfortable to assign grades at
the extremes of the mRS, possibly because these grades are
well-defined or because deviation can be in 1 direction only.
Therefore, we decided to proceed to use this relatively biased
sample.
Even with a training system, it may be impossible to
completely remove interobserver variability for the “diffi-
cult” midrange grades. For assessment cases 3 and 9, respon-
dents were almost evenly split between mRS grades 2 and 3.
This is not a failure of the training, rather an example of the
complexity of assigning fixed grades to real patients. We
anticipate that those video cases that have divided opinion
will be reviewed again by trainees, and discussion of these
cases with other investigators will facilitate further improve-
ment in mRS application. It is in the midrange of mRS grades
that the reliability of the scale assumes the greatest impor-
TABLE 2. mRS Gradings Submitted for Certification and Recertification, %*
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9
mRS 0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1
mRS 1 0.0 0.9 26.5 2.7 0.0 0.0 0.0 0.0 2.2
mRS 2 0.7 55 72.6 39.2 0.0 1.5 2.3 0.1 40.4
mRS 3 6.3 44.1 0.7 58.1 0.0 3.7 90.4 1.7 56.2
mRS 4 92.1 0.0 0.0 0.0 14 93.8 7.3 97.4 1.0
mRS 5 0.9 0.0 0.0 0.0 86 0.9 0.0 0.6 0.0
Correct grade 4 2 2 3 5 4 3 4 3
*To allow for future use of the assessment exercise, cases are not given in the order they appear on the DVD.
TABLE 3. Certification Scores by Background Training*
Position Not Qualified Qualified 3 Qualified 4 Qualified 5 Total
Coinvestigator 125 (16.7%) 96 (12.9%) 224 (30.0%) 302 (40.4%) 747
Principal investigator 28 (17.6%) 18 (11.3%) 48 (30.2%) 65 (40.9%) 159
Study nurse 53 (25%) 29 (13.7%) 64 (30.2%) 66 (31.1%) 212
Other 130 (19.0%) 71 (10.4%) 228 (33.4%) 253 (37.2%) 682
Total 336 214 564 686
*For explanation of “Qualified 5, 4, 3,” see Table 1.
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tance; mRS-based outcomes are frequently dichotomized,
with mRS4 defining poor outcome (STICH trial)3 or scores
2 defining good outcome (ECASS II).2 Given the problems
with midrange mRS grades highlighted by our data, increas-
ing use of nondichotomized trial end points should be
encouraged. To this end, the SAINT and CHANT trials
examined changes in mRS across the continuum of possible
grades.
It is difficult to adequately measure the “success” of a
multidimensional intervention such as an educational re-
source. Analyzing only “pass” rates for the assessment is a
relatively crude measure, as it is likely that even those
viewers who failed the initial certification will have gained
improved knowledge of the mRS scores and assessments.
Despite this, the high rate of satisfactory scoring on the
certification exercise is reassuring.
We gave assessors confidential feedback on their total
score. This allowed all users to review the cases and perhaps
to correct any grading errors. Data are not available for all of
the second attempts at certification, which raises the possi-
bility of sample bias, but the high “pass” rate seen provides
further support for utility of the training package. Given that
our training package is the only educational resource avail-
able for training, it is safe to assume that this improvement
was achieved with no extra tuition other than repeated
viewing of the package and knowledge of previous scoring.
Purists will argue that our data do not conclusively prove
the benefit of the training package. The primary purpose of
the package was to improve reliability of mRS grading in
large clinical trials, so we did not design a “control” arm of
assessors not exposed to training. Extrapolating evidence
from the success of the NIHSS and other video certification
schemes17 suggests this was a logical and ethically sound
decision. It is widely accepted that there is too little formal
guidance on application of the mRS,18 and few would argue
against an attempt at formalizing its use. Anecdotally, feed-
back from participants has been uniformly positive, and there
is little to suggest that exposure to the digital training worsens
mRS grading or introduces systematic bias. Even if the
training were to influence grading systematically, it could be
argued that if all assessors were taught to grade in the same
fashion and in a manner that reflects the mRS categories, that
this could only improve outcome assessments for trial
purposes.
Pragmatic evidence of the utility of the training package
comes from its application in the SAINT-I14 and CHANT15
studies. During conduct of these studies,1500 investigators
were trained. It cannot be proved that this improved the
quality of end-point assessment, but it does demonstrate the
feasibility of mass training. Given the inherent problems with
use of the mRS, it is unlikely not to have helped. We believe
that formal mRS training should be routine for all acute
stroke trials.
Even with the improvements in mRS grading offered by
use of the training package, there remains considerable scope
to further reduce interobserver variability. The increased
availability of affordable audiovisual equipment makes mul-
ticenter digital recording of mRS interviews feasible. Such an
approach would allow further review of interviews or “off-
line” assessment by other individuals or groups experienced
in the use of the scale. We are currently piloting the use of
such a scheme in our acute stroke unit.
It is recognized that some questions as to optimal delivery
of the package remain unanswered, such as how best to
address the issue of repeated failure to achieve certification
and whether training should be performed alone or in a group
setting with the opportunity to discuss the cases and content.
Work is ongoing to answer these questions.17 Already there is
scope for further improvements; for instance, making the
training available on the Internet could ease dissemination to
the target audience.
We recognize that many stroke researchers will not have
English as a first language. To facilitate improved mRS
scoring internationally, foreign language versions of the
training resource have been developed. It is interesting to note
that the majority of non-English–speaking countries, includ-
ing many that do not yet have a native language training
package, actually achieved better scores on the certification
exercise than did their UK counterparts.
Although accepted in the stroke literature from its incep-
tion, the mRS was not clinimetrically tested before its use.4
The data being collated from the mRS certification process
Certification scores by country. “Native” refers to native English-speaking countries; “non-English”, to countries where English is not
the first language. For explanation of “qualified 5, 4, 3,” see Table 1.
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provide a powerful tool for better definition of the properties
of the scale. Analysis of interobserver and intraobserver
variability of the scale with further subanalysis of individual
components of the scale and relations to country of origin and
level of training are ongoing.
We live in a digital age, and using the available technology
to deliver educational resources makes scientific and eco-
nomic sense. Strategies to improve the reliability of the mRS
are needed, and it is likely that electronic dissemination of
teaching material to participants in multicenter clinical trials
will be widely used in the future. We have demonstrated that
digital training in poststroke assessment is feasible and
accepted by most potential assessors. Further work to quan-
tify the potential impact of such training on the quality of
future stroke trials is required.
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